Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05831696 · ClinicalTrials.gov registry record · NA
Metabolic Cost of Walking With Passive vs. Powered Prosthetic Knees Among Persons With Limb Loss
A NA study of Transfemoral Amputation, sponsored by Loma Linda University.
- Recruiting
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT05831696: Recruiting NA study of Transfemoral Amputation, sponsored by Loma Linda University.
NCT05831696 is a NA study of Transfemoral Amputation that is actively recruiting participants, run by Loma Linda University. The registered enrollment target is 12 participants, below the 27-participant average among 8 other Transfemoral Amputation trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05831696, a NA study of Transfemoral Amputation, is actively recruiting participants, sponsored by Loma Linda University.
- RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this industry-initiated research study is to test that a powered microprocessor controlled knee improves metabolic function during walking in level and sloped conditions as compared to the subject's physician prescribed prosthesis.
Primary Outcome
VO2 uptake during ambulation on a treadmill - level ground
Conditions Studied
Interventions
- OTHER Powered Microprocessor-controlled Knee (PMPK)
Study Locations (1)
California
- Loma Linda University - Loma Linda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2023-02-27 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT05831696 shows while recruiting
NCT05831696 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 27-participant average among 8 other Transfemoral Amputation trials with a reported enrollment target (56% lower).
The record links to 1 condition, with Transfemoral Amputation appearing as the primary indexed condition, and to 1 intervention - of which Powered Microprocessor-controlled Knee (PMPK) is the first listed.
NCT05831696 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05831696 about?
NCT05831696 is a clinical study titled "Metabolic Cost of Walking With Passive vs. Powered Prosthetic Knees Among Persons With Limb Loss". The purpose of this industry-initiated research study is to test that a powered microprocessor controlled knee improves metabolic function during walking in level and sloped conditions as compared to the subject's physician prescribed prosthesis.
What is the current status of trial NCT05831696?
This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2023-02-27. Estimated completion is 2026-12.
What conditions does trial NCT05831696 study?
This clinical trial studies the following conditions: Transfemoral Amputation.
What interventions are being tested in trial NCT05831696?
The interventions under investigation include: Powered Microprocessor-controlled Knee (PMPK) (OTHER).
Who is sponsoring clinical trial NCT05831696?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05831696 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Transfemoral Amputation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05831696's enrollment target sits among peer trials
12 6th of 8 higher than 3 of 8 other Transfemoral Amputation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Transfemoral Amputation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of a Neural-Controlled Powered Prosthesis Across Diverse Real-World Tasks
RECRUITING · NA
-
A Biomechanical Evaluation of the Ossur Power Knee in Persons With Transfemoral Amputation
RECRUITING · NA
-
Active Knee Prosthesis Study
ACTIVE NOT RECRUITING · NA
-
Transfemoral Osseointegrated Prosthesis Limb-Load Symmetry Training
ACTIVE NOT RECRUITING · NA
-
Assist-Knee: Energy-Harvesting Knee Prosthesis
COMPLETED · NA
-
Sub-Ischial Socket for Transfemoral Amputation and Lower Mobility
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI